HIV inhibiting pyrimidines derivatives

US8080551B2 · kind B2 · utility

Assignee

• Janssen Pharmaceutica NA · BE

Inventors

• Jérôme Emile Georges Guillemont · Andé, FR
• Patrice Palandijian · Louviers, FR
• Marc René de Jonge · Tilburg, NL
• Lucien Maria Henricus Koymans · Retie, BE
• Hendrik Maarten Vinkers · Ekeren, BE
• Frederik Frans Desiré Daeyaert · Beerse, BE
• Jan Heeres · Vosselaar, BE
• Koen Jeanne Alfons Van Aken · Kortrijk, BE
• Paulus Joannes Lewi · Turnhout, BE
• Paul Adriaan Jan Janssen · Vosselaar, BE

Key dates

• Filing date: Jun 26, 2006
• Grant date: Dec 20, 2011
• Expiry date: Feb 26, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D417/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

HIV replication inhibitors having formula (I) defined herein are disclosed. Pharmaceutical compositions containing the HIV replication inhibitors; the use of the HIV replication inhibitors in the treatment of HIV; and processes for preparing the HIV replication inhibitors are also disclosed.